News
03-11-2009, 02:18 AM
Eli Lilly and Company has issued the following statement after being granted a temporary restraining order to halt the launch of a generic version of Evista (raloxifene HCl tablets) by Teva Pharmaceuticals.
More... (http://www.news-medical.net/?id=46726)
More... (http://www.news-medical.net/?id=46726)